Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure

Journal of Nuclear Medicine

Volumn 46, Issue 11, 2005, Pages 1775-1781

  Tipre, Dnyanesh N ^a,b   Goldstein, David S ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b MSC 1620 ^*  (United States)

Author keywords

Ammonia; Fluorodopamine; Parkinson's disease; PET; Pure autonomic failure

Indexed keywords

AMMONIA N 13; CATECHOLAMINE; DESIPRAMINE; DOPAMINE DERIVATIVE; FLUORODOPAMINE F 18; UNCLASSIFIED DRUG; 6 FLUORODOPAMINE; 6-FLUORODOPAMINE; DIAGNOSTIC AGENT; DOPAMINE; DRUG DERIVATIVE; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BODY REGIONS; CONTROLLED STUDY; DENERVATION; HUMAN; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NEUROPATHY; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HEART VENTRICLE; INNERVATION; MIDDLE AGED; PARKINSONISM; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME;

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM DISEASES; DESIPRAMINE; DOPAMINE; FLUORINE RADIOISOTOPES; HEART VENTRICLES; HUMANS; MIDDLE AGED; PARKINSONIAN DISORDERS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SHY-DRAGER SYNDROME; SYMPATHETIC NERVOUS SYSTEM;

EID: 33644821407     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Goldstein DS, Chang PC, Eisenhofer G, et al. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation. 1990;81:1606-1621.
2. Goldstein DS, Holmes C, Li ST, et al. Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med. 2000;133:338-347.
3. Goldstein DS, Holmes C, Cannon RO, et al. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med. 1997;336:696-702.
4. 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med. 2000;41:1594-1595.
5. Taki J, Nakajima K, Hwang EH, et al. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med. 2000;27:566-573.
6. Li ST, Dendi R, Holmes C, et al. Progressive loss of cardiac sympathetic innervation in Parkinson's disease. Ann Neurol. 2002;52:220-223.
7. 18F] Eluorodopamine positron emission tomo graphic scanning in the assessment of cardiac sympathoneural function: studies in normal humans. Clin Auton Res. 1997;7:17-29.
8. 15O]water techniques. Circulation. 1996;93:2000-2006.
9. 13N]ammonia. Cardiology. 1997;88:106-115.
10. Endo M, Yoshida K, Iinuma TA, et al. Noninvasive quantification of regional myocardial blood flow and ammonia extraction fraction using nitrogen-13 ammonia and positron emission tomography. Ann Nucl Med. 1987;1:1-6.
11. Goldstein DS, Robertson D, Esler M, et al. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med. 2002;137:753-763.
12. Tack CJ, van Gurp PJ, Holmes C, et al. Local sympathetic denervation in painful diabetic neuropathy. Diabetes. 2002;51:3545-3553.
13. Li ST, Tack CJ, Fananapazir L, et al. Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2000;35:1867-1873.
14. Goldstein DS, Tack C, Li ST. Sympathetic innervation and function in reflex sympathetic dystrophy. Ann Neurol. 2000;48:49-59.
15. Chang PC, Szemeredi K, Grossman E, et al. Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function. J Pharmacol Exp Ther. 1990;255:809-817.
16. Lockwood AH, McDonald JM, Reiman RE, et al. The dynamics of ammonia metabolism in man: effects of liver disease and hyperammonemia. J Clin Invest. 1979;63:449-460.
17. 18F]fluorodopamine in the human heart: a novel means to examine cardiac sympathetic neuronal function. Naunyn-Schmiedebergs Arch Pharmakol. 2002;365:38-49.
18. Goldstein DS. Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol. 2003;2:669-676.
19. Goldstein DS, Pechnik S, Holmes C, et al. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension. 2003;42: 136-142.
20. Goldstein DS, Holmes CS, Dendi R, et al. Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology. 2002;58:1247-1255.
21. Wenning GK, Scherfler C, Granata R, et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1999;67:620-623.